未登录

H

Hyungjin Rhee

Yonsei University

H指数:31

被引数:3,465

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deep learning–based auto-segmentation and RECIST evaluation after concurrent chemoradiotherapy in locally advanced hepatocellular carcinoma patients

基于深度学习的自动分割和RECIST评估在局部晚期肝细胞癌患者同步化放疗后的应用

Frontiers in Oncology

IF3.3

2026-04-050

OAAI

HCC surveillance after curative treatment: A new frontier for abbreviated MRI: Editorial on Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography

根治性治疗后对HCC的监测：简化MRI的新前沿：关于根治性治疗后晚期复发性肝细胞癌检测的非对比磁共振成像的社论：一项与对比增强计算机断层扫描的前瞻性多中心比较

Clinical and Molecular Hepatology

IF16.9

2026-04-011

PRE

Impact of metabolic dysfunction-associated steatotic liver disease on liver metastasis and survival in pancreatic cancer

代谢功能障碍相关脂肪性肝病对胰腺癌肝转移和生存的影响

World Journal of Gastroenterology

IF5.4

2026-03-210

PRE

Predicting early progression to atezolizumab–bevacizumab in hepatocellular carcinoma: a clinical and imaging-based scoring system

预测肝细胞癌患者早期进展至阿替利珠单抗–贝伐珠单抗的治疗反应：一种基于临床和影像学的评分系统

European Radiology

IF4.7

2025-10-040

PRE

Preoperative Prediction Model for Early Recurrence of Intrahepatic Cholangiocarcinoma after Surgical Resection: Development and External Validation Study

术后早期复发肝内胆管癌的术前预测模型：开发与外部验证研究

CANCER RESEARCH AND TREATMENT

IF3.8

2025-10-010

PRE

Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trial

噻唑烷二酮与钠-葡萄糖协同转运蛋白2抑制剂在2型糖尿病中治疗代谢功能障碍相关脂肪性肝病的协同效益：一项为期24周、开放标签、随机对照试验

IF8.3

2025-05-070

OA

Prediction of PD-L1 expression in unresectable hepatocellular carcinoma with gadoxetic acid-enhanced MRI

EUROPEAN JOURNAL OF RADIOLOGY

IF3.3

2024-12-010

PRE

MRI radiomics model differentiates small hepatic metastases and abscesses in periampullary cancer patients

SCIENTIFIC REPORTS

IF3.9

2024-10-090

OAAI

Saponins Derived from the Korean Endemic Plant Heloniopsis koreana Inhibit Diffuse-type Gastric Cancer Cells

IF4.3

2023-12-061

OAAI

Identification of novel pathogenic roles of BLZF1/ATF6 in tumorigenesis of gastrointestinal stromal tumor showing Golgi-localized mutant KIT

CELL DEATH AND DIFFERENTIATION

IF15.4

2023-09-131

OAAI

Differentiation between hepatic angiomyolipoma and hepatocellular carcinoma in individuals who are not at-risk for hepatocellular carcinoma

EUROPEAN JOURNAL OF RADIOLOGY

IF3.3

2023-09-010

PRE

ERS: A simple scoring system to predict early recurrence after surgical resection for hepatocellular carcinoma

LIVER INTERNATIONAL

IF5.2

2023-08-1413

OAAI

Costentin, Charlotte; Audureau, Etienne; Park, Young Nyun; Langella, Serena; Vibert, Eric; Laurent, Alexis; Cauchy, Francois; Scatton, Olivier; Chirica, Mircea; Rhaiem, Rami; Boleslawski, Emmanuel; di Tommaso, Luca; Ferrero, Alessandro; Yano, Hirohisa; Akiba, Jun; Donadon, Matteo; Nebbia, Martina; Detry, Olivier; Honore, Pierre; Di Martino, Marcello; Schwarz, Lilian; Barbier, Louise; Nault, Jean-Charles; Rhee, Hyungjin; Lim, Chetana; Brustia, Raffaele; Paradis, Valerie; Guettier, Catherine; Le Bail, Brigitte; Okumura, Shinya; Blanc, Jean-Frederic; Calderaro, Julien

Steatotic hepatocellular carcinoma: Association of MRI findings to underlying liver disease and clinicopathological characteristics

LIVER INTERNATIONAL

IF5.2

2023-04-234

PRE

A preoperative scoring system to predict lymph node metastasis in intrahepatic cholangiocarcinoma

HEPATOLOGY INTERNATIONAL

IF6.1

2023-01-2310

PRE

Albumin, filamin-A and cytokeratin 19 help distinguish intrahepatic cholangiocarcinoma from extrahepatic adenocarcinoma

白蛋白，纤维蛋白A和细胞角蛋白19有助于区分肝内胆管癌和肝外腺癌

HEPATOLOGY INTERNATIONAL

IF6.1

2022-10-173

PRE

Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)

IF8.3

2022-03-2150

OAAI

Molecular and radiopathologic spectrum between HCC and intrahepatic cholangiocarcinoma

IF15.8

2022-02-2627

PRE

Editorial for Multiparametric MRI-Based Radiomic Signature for Preoperative Evaluation of Overall Survival in Intrahepatic Cholangiocarcinoma After Partial Hepatectomy

JOURNAL OF MAGNETIC RESONANCE IMAGING

IF3.5

2022-02-250

PRE

Preoperative magnetic resonance imaging-based prognostic model for mass-forming intrahepatic cholangiocarcinoma

LIVER INTERNATIONAL

IF5.2

2022-02-2416

PRE

Lymphoepithelioma-like neoplasm of the biliary tract with 'probable low malignant potential'

IF4.1

2021-11-2514

OAAI